Arthritis Clinical Trials

Find Arthritis Clinical Trials Near You

Clinical Study of Bioceramic Materials in Bone Defect Repair

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to demonstrate the effect of bioceramic implants on the repair of human bone defects, and to explore the application of bioceramic materials in bone defects, bone implantation, and bone fusion. The surface microstructure of β-tricalcium phosphate bioceramic implants can be effectively controlled to guide the regeneration of bones, promote the restoration of bones, accelerate the speed of recovery, and improve bone quality, which is of great clinical and social significance.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Patients who voluntarily take the test and sign the informed consent form;

• Patients aged 18-65 years old with no history of allergies;

• Patients able to communicate well with the investigator and follow the requirements of the entire trial.

Locations
Other Locations
China
Nanjing First Hospital
RECRUITING
Nanjing
Contact Information
Primary
Qingqiang Yao, phD
yaoqingqiang@126.com
15366155699
Time Frame
Start Date: 2024-02-20
Estimated Completion Date: 2026-12-30
Participants
Target number of participants: 10
Treatments
Active_comparator: Commercial bone implant product Group
Bone repair products in the market such as artificial bones and allogeneic bones.
Experimental: Mirco-structured Bioceramic Group
β-Tricalcium phosphate (β-TCP) is a material with excellent biocompatibility and osteoinduction and bone guidance properties, which can provide mechanical strength equal to or better than that of human cancellous bone.
Related Therapeutic Areas
Sponsors
Leads: Nanjing First Hospital, Nanjing Medical University

This content was sourced from clinicaltrials.gov